1-3 of 3
Maria Badillo, BS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ibrutinib and Rituximab Are an Efficacious and Safe Combination in Relapsed Mantle Cell Lymphoma: Preliminary Results from a Phase II Clinical Trial

Free
Michael (Luhua) Wang, MD, Fredrick Hagemeister, MD, Jason R. Westin, MD, Luis Fayad, MD, Felipe Samaniego, MD, Francesco Turturro, MD, Wendy Chen, Liang Zhang, MD PhD, Maria Badillo, BS, Maria DeLa Rosa, Alicia Addison, Larry W. Kwak, MD PhD, Jorge E. Romaguera, MD
Journal: Blood
Blood (2014) 124 (21): 627.
https://doi.org/10.1182/blood.V124.21.627.627
Published: 2014
Journal Articles

Novel Combination Of Lenalidomide-Rituximab Provides An Effective Bridge To Stem Cell Transplantation In Relapsed and/Or Refractory Aggressive B-Cell Non-Hodgkin’s Lymphomas: A Single Center Experience

Free
Qingqing Cai, MD, PhD, Yiming Chen, MD., PhD., Dehui Zou, Maria Badillo, BS, Shouhao Zhou, PhD, Liang Zhang, MD, PhD, Elyse R Lopez, Wenqi Jiang, MD, PhD, Hui-qiang Huang, MD, PhD, Tongyu Lin, MD, PhD, Michael Wang, MD
Journal: Blood
Blood (2013) 122 (21): 3056.
https://doi.org/10.1182/blood.V122.21.3056.3056
Published: 2013
Journal Articles

Phase II Trial Of Bortezomib In Combination With Fractionated Cyclophosphamide and Rituximab (BCR) For Relapsed/Refractory Mantle Cell Lymphoma (MCL)

Free
Jorge E Romaguera, MD, Michelle A. Fanale, MD, Felipe Samaniego, M.D., M.P.H, Luis E Fayad, Fredrick B Hagemeister, MD, Peter McLaughlin, MD, Maria Alma Rodriguez, MD, Pam Weaver, Kim Hartig, Maria Badillo, BS, Larry W. Kwak, MD, PhD, Anas Younes, MD, Barbara Pro, MD, Michael Wang, MD
Journal: Blood
Blood (2013) 122 (21): 5122.
https://doi.org/10.1182/blood.V122.21.5122.5122
Published: 2013